BridgeBio Pharma, Inc. (BBIO)
77.19
+0.93
(+1.22%)
USD |
NASDAQ |
Jan 20, 16:00
77.00
-0.19
(-0.25%)
After-Hours: 05:36
BridgeBio Pharma Market Cap: 14.88B for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 145.10B |
| Alnylam Pharmaceuticals, Inc. | 46.97B |
| Supernus Pharmaceuticals, Inc. | 2.857B |
| Ionis Pharmaceuticals, Inc. | 12.56B |
| Sarepta Therapeutics, Inc. | 2.205B |
Market Cap Related Metrics
| PS Ratio | 41.56 |
| PEG Ratio | -0.2506 |
| Price | 77.19 |
| Earnings Yield | -5.42% |
| PEGY Ratio | -0.2506 |